Search research articles
Contact Us
Filters
Showing results (11-20 of 49) with videos related to
Page
of 5
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
May 13, 2020
Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy
Benedetta Maria Bonora, Federico Boscari, Angelo Avogaro, et al.
Diabetes Care
|
November 6, 2016
Long-term Prediction of Cardiovascular Outcomes by Circulating CD34+ and CD34+CD133+ Stem Cells in Patients With Type 2 Diabetes
Gian Paolo Fadini, Mauro Rigato, Roberta Cappellari, et al.
Metabolic Syndrome and Related Disorders
|
March 4, 2015
Synergistic interactions among metabolic syndrome components and homeostasis model assessment of insulin resistance in a middle-aged general population over time
Benedetta Maria Bonora, Mariacristina Marescotti, Giorgio Marcuzzo, et al.
Cardiovascular Diabetology
|
August 16, 2019
Effects of the SGLT2 inhibitor dapagliflozin on cardiac function evaluated by impedance cardiography in patients with type 2 diabetes. Secondary analysis of a randomized placebo-controlled trial
Benedetta Maria Bonora, Saula Vigili de Kreutzenberg, Angelo Avogaro, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 17, 2018
Effects of SGLT2 Inhibitors on Circulating Stem and Progenitor Cells in Patients With Type 2 Diabetes
Benedetta Maria Bonora, Roberta Cappellari, Mattia Albiero, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets
|
June 22, 2023
Ketosis-prone Diabetes and Hypogonadism: A New Clinical Association to be Aware of ?
Andrea Graziani, Riccardo Maria Pollis, Benedetta Maria Bonora, et al.
Diabetes, Obesity & Metabolism
|
October 21, 2017
Dipeptidyl peptidase-4 inhibitors moderate the risk of genitourinary tract infections associated with sodium-glucose co-transporter-2 inhibitors
Gian Paolo Fadini, Benedetta Maria Bonora, Sarangdhar Mayur, et al.
Diabetes, Obesity & Metabolism
|
January 2, 2026
The importance of treatment sequencing with SGLT2 inhibitors and GLP-1 receptor agonists combination for kidney function preservation in type 2 diabetes
Mario Luca Morieri, Monica Vedovato, Benedetta Maria Bonora, et al.
Diabetes, Obesity & Metabolism
|
May 10, 2026
Estimated Oral Semaglutide Exposure Has Distinct Relationships With Glycaemic Response, Weight Loss and Gastrointestinal Tolerability
Gian Paolo Fadini, Mario Luca Morieri, Carlotta Boscaro, et al.
Diabetes/Metabolism Research and Reviews
|
April 25, 2025
Long-Term Effectiveness of Once-Weekly Semaglutide in Patients With Type 2 Diabetes Previously Treated With Insulin. A Multicentre Real-World Study
Benedetta Maria Bonora, Andrea Giaccari, Agostino Consoli, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 49) with videos related to
Sort By:
Page
of 5
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
May 13, 2020
Glycaemic Control Among People with Type 1 Diabetes During Lockdown for the SARS-CoV-2 Outbreak in Italy
Benedetta Maria Bonora, Federico Boscari, Angelo Avogaro, et al.
Diabetes Care
|
November 6, 2016
Long-term Prediction of Cardiovascular Outcomes by Circulating CD34+ and CD34+CD133+ Stem Cells in Patients With Type 2 Diabetes
Gian Paolo Fadini, Mauro Rigato, Roberta Cappellari, et al.
Metabolic Syndrome and Related Disorders
|
March 4, 2015
Synergistic interactions among metabolic syndrome components and homeostasis model assessment of insulin resistance in a middle-aged general population over time
Benedetta Maria Bonora, Mariacristina Marescotti, Giorgio Marcuzzo, et al.
Cardiovascular Diabetology
|
August 16, 2019
Effects of the SGLT2 inhibitor dapagliflozin on cardiac function evaluated by impedance cardiography in patients with type 2 diabetes. Secondary analysis of a randomized placebo-controlled trial
Benedetta Maria Bonora, Saula Vigili de Kreutzenberg, Angelo Avogaro, et al.
The Journal of Clinical Endocrinology and Metabolism
|
August 17, 2018
Effects of SGLT2 Inhibitors on Circulating Stem and Progenitor Cells in Patients With Type 2 Diabetes
Benedetta Maria Bonora, Roberta Cappellari, Mattia Albiero, et al.
Endocrine, Metabolic & Immune Disorders Drug Targets
|
June 22, 2023
Ketosis-prone Diabetes and Hypogonadism: A New Clinical Association to be Aware of ?
Andrea Graziani, Riccardo Maria Pollis, Benedetta Maria Bonora, et al.
Diabetes, Obesity & Metabolism
|
October 21, 2017
Dipeptidyl peptidase-4 inhibitors moderate the risk of genitourinary tract infections associated with sodium-glucose co-transporter-2 inhibitors
Gian Paolo Fadini, Benedetta Maria Bonora, Sarangdhar Mayur, et al.
Diabetes, Obesity & Metabolism
|
January 2, 2026
The importance of treatment sequencing with SGLT2 inhibitors and GLP-1 receptor agonists combination for kidney function preservation in type 2 diabetes
Mario Luca Morieri, Monica Vedovato, Benedetta Maria Bonora, et al.
Diabetes, Obesity & Metabolism
|
May 10, 2026
Estimated Oral Semaglutide Exposure Has Distinct Relationships With Glycaemic Response, Weight Loss and Gastrointestinal Tolerability
Gian Paolo Fadini, Mario Luca Morieri, Carlotta Boscaro, et al.
Diabetes/Metabolism Research and Reviews
|
April 25, 2025
Long-Term Effectiveness of Once-Weekly Semaglutide in Patients With Type 2 Diabetes Previously Treated With Insulin. A Multicentre Real-World Study
Benedetta Maria Bonora, Andrea Giaccari, Agostino Consoli, et al.
Page
of 5